Terms: = Brain cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
92 results:
1. Meningioma: current updates on genetics, classification, and mouse modeling.
Szulzewsky F; Thirimanne HN; Holland EC
Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
[TBL] [Abstract] [Full Text] [Related]
2. Imaging as an early biomarker to predict sensitivity to everolimus for progressive nf2-related vestibular schwannoma.
Nghiemphu PL; Vitte J; Dombi E; Nguyen T; Wagle N; Ishiyama A; Sepahdari AR; Cachia D; Widemann BC; Brackmann DE; Doherty JK; Kalamarides M; Giovannini M
J Neurooncol; 2024 Apr; 167(2):339-348. PubMed ID: 38372904
[TBL] [Abstract] [Full Text] [Related]
3. schwannomatosis: a Realm Reborn: year one.
Planet M; Kalamarides M; Peyre M
Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
[TBL] [Abstract] [Full Text] [Related]
4. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
Wagener K; Beckhaus J; Boekhoff S; Friedrich C; Müller HL
J Neurooncol; 2023 Jul; 163(3):555-563. PubMed ID: 37402092
[TBL] [Abstract] [Full Text] [Related]
5. Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.
Eraky AM; Beck RT; Treffy RW; Aaronson DM; Hedayat H
J Integr Neurosci; 2023 May; 22(3):73. PubMed ID: 37258452
[TBL] [Abstract] [Full Text] [Related]
6. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
[TBL] [Abstract] [Full Text] [Related]
7. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic
Brastianos PK; Twohy EL; Gerstner ER; Kaufmann TJ; Iafrate AJ; Lennerz J; Jeyapalan S; Piccioni DE; Monga V; Fadul CE; Schiff D; Taylor JW; Chowdhary SA; Bettegowda C; Ansstas G; De La Fuente M; Anderson MD; Shonka N; Damek D; Carrillo J; Kunschner-Ronan LJ; Chaudhary R; Jaeckle KA; Senecal FM; Kaley T; Morrison T; Thomas AA; Welch MR; Iwamoto F; Cachia D; Cohen AL; Vora S; Knopp M; Dunn IF; Kumthekar P; Sarkaria J; Geyer S; Carrero XW; Martinez-Lage M; Cahill DP; Brown PD; Giannini C; Santagata S; Barker FG; Galanis E
J Clin Oncol; 2023 Jan; 41(3):618-628. PubMed ID: 36288512
[TBL] [Abstract] [Full Text] [Related]
8. Nervous system (NS) Tumors in cancer Predisposition Syndromes.
Patil P; Pencheva BB; Patil VM; Fangusaro J
Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
[TBL] [Abstract] [Full Text] [Related]
9. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
[TBL] [Abstract] [Full Text] [Related]
10. [The Potential of Personalized/Precision Medicine for Meningiomas].
Yamaguchi S; Fujimura M
No Shinkei Geka; 2022 Jan; 50(1):132-140. PubMed ID: 35169093
[TBL] [Abstract] [Full Text] [Related]
11. Lysine Demethylase 6B Regulates Prostate cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract] [Full Text] [Related]
12. Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in merlin-Negative schwannoma and Meningioma.
Maze EA; Agit B; Reeves S; Hilton DA; Parkinson DB; Laraba L; Ercolano E; Kurian KM; Hanemann CO; Belshaw RD; Ammoun S
Cancer Res; 2022 Jan; 82(2):235-247. PubMed ID: 34853069
[TBL] [Abstract] [Full Text] [Related]
13. Phase 0 Clinical Trial of Everolimus in Patients with Vestibular schwannoma or Meningioma.
Karajannis MA; Mauguen A; Maloku E; Xu Q; Dunbar EM; Plotkin SR; Yaffee A; Wang S; Roland JT; Sen C; Placantonakis DG; Golfinos JG; Allen JC; Vitanza NA; Chiriboga LA; Schneider RJ; Deng J; Neubert TA; Goldberg JD; Zagzag D; Giancotti FG; Blakeley JO
Mol Cancer Ther; 2021 Sep; 20(9):1584-1591. PubMed ID: 34224367
[TBL] [Abstract] [Full Text] [Related]
14. Skull Base Tumors: Neuropathology and Clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract] [Full Text] [Related]
15. Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
Mohammed N; Hung YC; Xu Z; Chytka T; Liscak R; Tripathi M; Arsanious D; Cifarelli CP; Perez Caceres M; Mathieu D; Speckter H; Mehta GU; Lekovic GP; Sheehan JP
J Neurosurg; 2022 Jan; 136(1):109-114. PubMed ID: 34144518
[TBL] [Abstract] [Full Text] [Related]
16. Current Understanding of Neurofibromatosis Type 1, 2, and schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract] [Full Text] [Related]
17. Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.
Behling F; Fodi C; Skardelly M; Renovanz M; Castaneda S; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J
Neurosurg Rev; 2022 Feb; 45(1):467-478. PubMed ID: 33899156
[TBL] [Abstract] [Full Text] [Related]
18. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
[TBL] [Abstract] [Full Text] [Related]
19. A nationwide population-based study on overall survival after meningioma surgery.
Champeaux-Depond C; Weller J; Froelich S; Resche-Rigon M
Cancer Epidemiol; 2021 Feb; 70():101875. PubMed ID: 33360358
[TBL] [Abstract] [Full Text] [Related]
20. Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.
Forde C; King AT; Rutherford SA; Hammerbeck-Ward C; Lloyd SK; Freeman SR; Pathmanaban ON; Stapleton E; Thomas OM; Laitt RD; Stivaros S; Kilday JP; Vassallo G; McBain C; Kerrigan S; Smith MJ; McCabe MG; Harkness EF; Evans DG
Neuro Oncol; 2021 Jul; 23(7):1113-1124. PubMed ID: 33336705
[TBL] [Abstract] [Full Text] [Related]
[Next]
